dapi has been researched along with 8-bromo cyclic adenosine monophosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandt, R; Kaplan, D; Laliberté, C; Shahani, N; Strelau, J; Subramaniam, S; Unsicker, K | 1 |
1 other study(ies) available for dapi and 8-bromo cyclic adenosine monophosphate
Article | Year |
---|---|
Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Animals, Newborn; Blotting, Western; Cell Survival; Cells, Cultured; Cerebellum; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Green Fluorescent Proteins; Immunohistochemistry; In Situ Nick-End Labeling; Indoles; Insulin-Like Growth Factor I; Neurons; Phosphatidylinositol 3-Kinases; Potassium Chloride; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Signal Transduction; Time Factors; Transfection | 2005 |